{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:18:08Z","timestamp":1790619488806,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"CCRUM-SRF","award":["3-15\/2021-CCRUM\/Tech"],"award-info":[{"award-number":["3-15\/2021-CCRUM\/Tech"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00210-026-05089-z","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T08:43:34Z","timestamp":1771231414000},"page":"11343-11363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Application of Box\u2013Behnken design for the development of bilosome-mediated dual delivery of ascorbic acid and piperine: characterization, in silico and in vitro investigations"],"prefix":"10.1007","volume":"399","author":[{"given":"Rizwan","family":"Ahamad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazreen","family":"Tabassum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Ahad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Aqil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mairaj Ahmad","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Mujeeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"5089_CR1","doi-asserted-by":"publisher","unstructured":"Ahamad R, Tabassum N, K P R, Singh S, Singh G, Akhtar M, Akil M, Mujeeb M (2022) World J Pharm Pharm Sci 1267\u20131283. https:\/\/doi.org\/10.20959\/wjpps20259-30518","DOI":"10.20959\/wjpps20259-30518"},{"issue":"9","key":"5089_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091771","volume":"14","author":"A Alhalmi","year":"2022","unstructured":"Alhalmi A, Amin S, Khan Z, Beg S, Al Kamaly O, Saleh A, Kohli K (2022) Nanostructured lipid carrier-based codelivery of raloxifene and naringin: formulation, optimization, in vitro, ex vivo, in vivo assessment, and acute toxicity studies. Pharmaceutics 14(9):1771. https:\/\/doi.org\/10.3390\/pharmaceutics14091771","journal-title":"Pharmaceutics"},{"issue":"1","key":"5089_CR3","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1080\/10717544.2022.2122634","volume":"29","author":"NK Alruwaili","year":"2022","unstructured":"Alruwaili NK, Zafar A, Alsaidan OA, Yasir M, Mostafa EM, Alnomasy SF, Alomar FA (2022) Development of surface modified bilosomes for the oral delivery of quercetin: optimization, characterization in-vitro antioxidant, antimicrobial, and cytotoxicity study. Drug Deliv 29(1):3035\u20133050. https:\/\/doi.org\/10.1080\/10717544.2022.2122634","journal-title":"Drug Deliv"},{"issue":"11","key":"5089_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/pr8111450","volume":"8","author":"S Alshehri","year":"2020","unstructured":"Alshehri S, Imam SS, Hussain A, Altamimi MA (2020) Formulation of piperine ternary inclusion complex using \u03b2 CD and HPMC: physicochemical characterization, molecular docking, and antimicrobial testing. Processes 8(11):1450. https:\/\/doi.org\/10.3390\/pr8111450","journal-title":"Processes"},{"issue":"5","key":"5089_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9050359","volume":"9","author":"M Attia","year":"2020","unstructured":"Attia M, Essa EA, Zaki RM, Elkordy AA (2020) An overview of the antioxidant effects of ascorbic acid and alpha lipoic acid (in liposomal forms) as adjuvant in cancer treatment. Antioxidants 9(5):359. https:\/\/doi.org\/10.3390\/antiox9050359","journal-title":"Antioxidants"},{"issue":"1","key":"5089_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2500\/jfa.2024.6.240003","volume":"6","author":"JA Bellanti","year":"2024","unstructured":"Bellanti JA (2024) Ige and non-IgE food allergy: a review of immunological mechanisms. J Food Allergy 6(1):37\u201346. https:\/\/doi.org\/10.2500\/jfa.2024.6.240003","journal-title":"J Food Allergy"},{"issue":"2","key":"5089_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2174\/138920010791110836","volume":"11","author":"Z Cai","year":"2010","unstructured":"Cai Z, Wang Y, Zhu LJ, Liu ZQ (2010) Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs. CurrentDrugMetabolism 11(2):197\u2013207. https:\/\/doi.org\/10.2174\/138920010791110836","journal-title":"CurrentDrugMetabolism"},{"issue":"1","key":"5089_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2174\/1874842201603010075","volume":"3","author":"B Chopra","year":"2016","unstructured":"Chopra B, Dhingra AK, Kapoor RP, Prasad DN (2016) Piperine and its various physicochemical and biological aspects: a review. Open Chemistry Journal 3(1):75\u201396. https:\/\/doi.org\/10.2174\/1874842201603010075","journal-title":"Open Chemistry Journal"},{"key":"5089_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2025.09.035","author":"BJ Day","year":"2025","unstructured":"Day BJ, Huang J, Schaunaman N, Downey GP, Chu HW (2025) Pro-inflammatory and oxidative responses to burn pit relevant desert particulate matter in macrophages: a role for TLR2 signaling. Free Radic Biol Med. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.09.035","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"5089_CR10","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-019-1597-3","volume":"21","author":"Z Dong","year":"2020","unstructured":"Dong Z, Iqbal S, Zhao Z (2020) Preparation of ergosterol-loaded nanostructured lipid carriers for enhancing oral bioavailability and antidiabetic nephropathy effects. AAPS PharmSciTech 21(2):64. https:\/\/doi.org\/10.1208\/s12249-019-1597-3","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"5089_CR11","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1080\/10717544.2022.2110997","volume":"29","author":"MH Elkomy","year":"2022","unstructured":"Elkomy MH, Eid HM, Elmowafy M, Shalaby K, Zafar A, Abdelgawad MA, Abou-Taleb HA (2022) Bilosomes as a promising nanoplatform for oral delivery of an alkaloid nutraceutical: improved pharmacokinetic profile and snowballed hypoglycemic effect in diabetic rats. Drug Deliv 29(1):2694\u20132704. https:\/\/doi.org\/10.1080\/10717544.2022.2110997","journal-title":"Drug Deliv"},{"issue":"9","key":"5089_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2023.103778","volume":"30","author":"NA Emad","year":"2023","unstructured":"Emad NA, Sultana Y, Aqil M, Saleh A, Nasr FA (2023) Omega-3 fatty acid- based self-microemulsifying drug delivery system (SMEDDS) of pioglitazone: optimization, in vitro and in vivo studies. Saudi J Biol Sci 30(9):103778. https:\/\/doi.org\/10.1016\/j.sjbs.2023.103778","journal-title":"Saudi J Biol Sci"},{"key":"5089_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.753599","volume":"12","author":"S Fan","year":"2021","unstructured":"Fan S, Wang Y, Zhang Y, Wu Y, Chen X (2021) Achyranthes bidentata polysaccharide activates nuclear factor-kappa B and promotes cytokine production in J774A. 1 cells through TLR4\/MyD88 signaling pathway. Front Pharmacol 12:753599. https:\/\/doi.org\/10.3389\/fphar.2021.753599","journal-title":"Front Pharmacol"},{"key":"5089_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1213448","volume":"14","author":"N Gonzalez Caldito","year":"2023","unstructured":"Gonzalez Caldito N (2023) Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders. Front Immunol 14:1213448. https:\/\/doi.org\/10.3389\/fimmu.2023.1213448","journal-title":"Front Immunol"},{"key":"5089_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jhazmat.2016.12.048","volume":"327","author":"X Hou","year":"2017","unstructured":"Hou X, Huang X, Ai Z, Zhao J, Zhang L (2017) Ascorbic acid induced atrazine degradation. Journalofhazardousmaterials 327:71\u201378. https:\/\/doi.org\/10.1016\/j.jhazmat.2016.12.048","journal-title":"Journalofhazardousmaterials"},{"issue":"12","key":"5089_CR16","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1517\/17425247.2014.945420","volume":"11","author":"SR Hwang","year":"2014","unstructured":"Hwang SR, Byun Y (2014) Advances in oral macromolecular drug delivery. Expert Opin Drug Deliv 11(12):1955\u20131967. https:\/\/doi.org\/10.1517\/17425247.2014.945420","journal-title":"Expert Opin Drug Deliv"},{"issue":"20","key":"5089_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25204716","volume":"25","author":"SS Imam","year":"2020","unstructured":"Imam SS, Alshehri S, Alzahrani TA, Hussain A, Altamimi MA (2020) Formulation and evaluation of supramolecular food-grade piperine HP \u03b2 CD and TPGS complex: dissolution, physicochemical characterization, molecular docking, in vitro antioxidant activity, and antimicrobial assessment. Molecules 25(20):4716. https:\/\/doi.org\/10.3390\/molecules25204716","journal-title":"Molecules"},{"key":"5089_CR18","doi-asserted-by":"publisher","unstructured":"Islam N, Zahoor AF, Syed HK, Iqbal MS, Khan IU, Abbas G, ..., Irfan M (2020) Improvement of solubility and dissolution of ebastine by fabricating phosphatidylcholine\/bile salt bilosomes. Pak J Pharm Sci 33. https:\/\/doi.org\/10.36721\/PJPS.2020.33.5.SUP.2301-2306.1","DOI":"10.36721\/PJPS.2020.33.5.SUP.2301-2306.1"},{"issue":"6","key":"5089_CR19","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-022-02339-0","volume":"23","author":"A Ismail","year":"2022","unstructured":"Ismail A, Teiama M, Magdy B, Sakran W (2022) Development of a novel bilosomal system for improved oral bioavailability of sertraline hydrochloride: formulation design, in vitro characterization, and ex vivo and in vivo studies. AAPS PharmSciTech 23(6):188. https:\/\/doi.org\/10.1208\/s12249-022-02339-0","journal-title":"AAPS PharmSciTech"},{"key":"5089_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00878","volume":"10","author":"I Jantan","year":"2019","unstructured":"Jantan I, Haque MA, Ilangkovan M, Arshad L (2019) An insight into the modulatory effects and mechanisms of action of Phyllanthus species and their bioactive metabolites on the immune system. Front Pharmacol 10:878. https:\/\/doi.org\/10.3389\/fphar.2019.00878","journal-title":"Front Pharmacol"},{"issue":"1","key":"5089_CR21","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1080\/10717544.2022.2120925","volume":"29","author":"M Kharouba","year":"2022","unstructured":"Kharouba M, El-Kamel A, Mehanna R, Thabet E, Heikal L (2022) Pitavastatin- loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach. Drug Deliv 29(1):2925\u20132944. https:\/\/doi.org\/10.1080\/10717544.2022.2120925","journal-title":"Drug Deliv"},{"issue":"12","key":"5089_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/membranes12121215","volume":"12","author":"M Krajewska","year":"2022","unstructured":"Krajewska M, Dopiera\u0142a K, Prochaska K (2022) The biomimetic system of oleanolic acid and oleic acid at the air-water interface\u2013interactions in terms of nanotechnology- based drugdeliverysystems. Membranes 12(12):1215. https:\/\/doi.org\/10.3390\/membranes12121215","journal-title":"Membranes"},{"issue":"1","key":"5089_CR23","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/10717544.2018.1455763","volume":"25","author":"W Li","year":"2018","unstructured":"Li W, Wu J, Zhang J, Wang J, Xiang D, Luo S, Li J, Liu X (2018) Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile. Drug Deliv 25(1):827\u2013837. https:\/\/doi.org\/10.1080\/10717544.2018.1455763","journal-title":"Drug Deliv"},{"key":"5089_CR24","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.ejmech.2019.01.007","volume":"164","author":"M Li","year":"2019","unstructured":"Li M, Du C, Guo N, Teng Y, Meng X, Sun H, Galons H (2019) Composition design and medical application of liposomes. Eur J Med Chem 164:640\u2013653. https:\/\/doi.org\/10.1016\/j.ejmech.2019.01.007","journal-title":"Eur J Med Chem"},{"issue":"2","key":"5089_CR25","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-024-02747-4","volume":"25","author":"R Maheshwari","year":"2024","unstructured":"Maheshwari R, Bhatt LK, Wairkar S (2024) Enhanced oral bioavailability of progesterone in bilosome formulation: fabrication, statistical optimization, and pharmacokinetic study. AAPS PharmSciTech 25(2):29. https:\/\/doi.org\/10.1208\/s12249-024-02747-4","journal-title":"AAPS PharmSciTech"},{"key":"5089_CR26","doi-asserted-by":"crossref","unstructured":"Mandlik D, Mandlik S, Rajput A (2022) Herbal bioenhancers and improvement of the bioavailability of drugs In: Drug Delivery Technology: Herbal Bioenhancers in Pharmaceuticals, Prashant L. Pingale (ed), p 211. Walter de Gruyter GmbH & Co KG, Berlin, Germany","DOI":"10.1515\/9783110746808-008"},{"issue":"Suppl 3","key":"5089_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-024-00932-5","volume":"20","author":"JS Marshall","year":"2024","unstructured":"Marshall JS, Upton JE, Vliagoftis H, Hildebrand KJ, Byrne A, Watson W (2024) Introduction to immunology and immune disorders. Allergy Asthma Clin Immunol 20(Suppl 3):69. https:\/\/doi.org\/10.1186\/s13223-024-00932-5","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"2","key":"5089_CR28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/bab.2672","volume":"72","author":"S Mohan","year":"2025","unstructured":"Mohan S, Thankaswamy J (2025) Synthesis and characterization of piperine-modified mesoporous silica nanoparticles for biomedical applications. Biotechnol Appl Biochem 72(2):402\u2013414. https:\/\/doi.org\/10.1002\/bab.2672","journal-title":"Biotechnol Appl Biochem"},{"key":"5089_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.570122","volume":"11","author":"M Mrityunjaya","year":"2020","unstructured":"Mrityunjaya M, Pavithra V, Neelam R, Janhavi P, Halami PM, Ravindra PV (2020) Immune-boosting, antioxidant and anti-inflammatory food supplements targeting pathogenesis of COVID-19. Front Immunol 11:570122. https:\/\/doi.org\/10.3389\/fimmu.2020.570122","journal-title":"Front Immunol"},{"issue":"1","key":"5089_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-023-03954-x","volume":"19","author":"A Muheem","year":"2024","unstructured":"Muheem A, Wasim M, Aldosari E, Baboota S, Ali J (2024) Fabrication of TPGS decorated Etravirine loaded lipidic nanocarriers as a neoteric oral bioavailability enhancer for lymphatic targeting. Discov Nano 19(1):5. https:\/\/doi.org\/10.1186\/s11671-023-03954-x","journal-title":"Discov Nano"},{"issue":"2","key":"5089_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1021\/acsfoodscitech.3c00575","volume":"4","author":"MA Munir","year":"2024","unstructured":"Munir MA, Jamal JA, Inayatullah A (2024) Environment-friendly approach to isolate ascorbic acid from plants and micro-identified using Fourier transform infrared spectroscopy. ACS Food Sci Technol 4(2):501\u2013506. https:\/\/doi.org\/10.1021\/acsfoodscitech.3c00575","journal-title":"ACS Food Sci Technol"},{"issue":"9","key":"5089_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091798","volume":"14","author":"Z N\u00e9meth","year":"2022","unstructured":"N\u00e9meth Z, Cs\u00f3ka I, Semnani Jazani R, Sipos B, Haspel H, Kozma G, Dob\u00f3 DG (2022) Quality by design-driven zeta potential optimisation study of liposomes with charge impartingmembraneadditives. Pharmaceutics 14(9):1798. https:\/\/doi.org\/10.3390\/pharmaceutics14091798","journal-title":"Pharmaceutics"},{"issue":"78","key":"5089_CR33","doi-asserted-by":"publisher","first-page":"73986","DOI":"10.1039\/C6RA10978K","volume":"6","author":"M Nurunnabi","year":"2016","unstructured":"Nurunnabi M, Khatun Z, Revuri V, Nafiujjaman M, Cha S, Cho S, Lee YK (2016) Design and strategies for bile acid mediated therapy and imaging. RSC Adv 6(78):73986\u201374002. https:\/\/doi.org\/10.1039\/C6RA10978K","journal-title":"RSC Adv"},{"issue":"4","key":"5089_CR34","doi-asserted-by":"publisher","first-page":"312","DOI":"10.2174\/1574885514666190917145510","volume":"15","author":"P Palekar-Shanbhag","year":"2020","unstructured":"Palekar-Shanbhag P, Lande S, Chandra R, Rane D (2020) Bilosomes: superior vesicularcarriers. Currentdrugtherapy 15(4):312\u2013320. https:\/\/doi.org\/10.2174\/1574885514666190917145510","journal-title":"Currentdrugtherapy"},{"issue":"1","key":"5089_CR35","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1080\/19476337.2018.1437080","volume":"16","author":"L Pan","year":"2018","unstructured":"Pan L, Zhang S, Gu K, Zhang N (2018) Preparation of astaxanthin-loaded liposomes: characterization, storage stability and antioxidant activity. CyTA-J Food 16(1):607\u2013618. https:\/\/doi.org\/10.1080\/19476337.2018.1437080","journal-title":"CyTA-J Food"},{"issue":"11","key":"5089_CR36","doi-asserted-by":"publisher","first-page":"6178","DOI":"10.1016\/j.sjbs.2021.06.076","volume":"28","author":"A Parveen","year":"2021","unstructured":"Parveen A, Zahiruddin S, Agarwal N, Siddiqui MA, Ansari SH, Ahmad S (2021) Modulating effects of the synergistic combination of extracts of herbal drugs on cyclophosphamide-induced immunosuppressed mice. Saudi J Biol Sci 28(11):6178\u20136190. https:\/\/doi.org\/10.1016\/j.sjbs.2021.06.076","journal-title":"Saudi J Biol Sci"},{"key":"5089_CR37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.colsurfb.2018.11.025","volume":"174","author":"A Praveen","year":"2019","unstructured":"Praveen A, Aqil M, Imam SS, Ahad A, Moolakkadath T, Ahmad FJ (2019) Lamotrigine encapsulated intra-nasal nanoliposome formulation for epilepsy treatment: formulation design, characterization and nasal toxicity study. Colloids Surf B Biointerfaces 174:553\u2013562. https:\/\/doi.org\/10.1016\/j.colsurfb.2018.11.025","journal-title":"Colloids Surf B Biointerfaces"},{"key":"5089_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemphyslip.2020.105005","volume":"234","author":"S Rehman","year":"2021","unstructured":"Rehman S, Nabi B, Baboota S, Ali J (2021) Tailoring lipid nanoconstructs for the oral delivery of paliperidone: formulation, optimization and in vitro evaluation. Chem Phys Lipids 234:105005. https:\/\/doi.org\/10.1016\/j.chemphyslip.2020.105005","journal-title":"Chem Phys Lipids"},{"key":"5089_CR39","doi-asserted-by":"publisher","unstructured":"Sadia H, Qureshi IZ, Naveed M, Aziz T, Elkhadragy MF, Alwethaynani MS, ..., Al-Joufi FA (2025) Molecular simulation and expression analysis of vitamin c and curcumin in mitigating buprofezin-induced genotoxicity and inflammatory responses in Balb\/c mice. Cell Biochem Biophys 1\u201326. https:\/\/doi.org\/10.1007\/s12013-025-01891-3","DOI":"10.1007\/s12013-025-01891-3"},{"key":"5089_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101634","volume":"57","author":"Z Saifi","year":"2020","unstructured":"Saifi Z, Rizwanullah M, Mir SR, Amin S (2020) Bilosomes nanocarriers for improved oral bioavailability of acyclovir: a complete characterization through in vitro, ex- vivo and in vivo assessment. J Drug Deliv Sci Technol 57:101634. https:\/\/doi.org\/10.1016\/j.jddst.2020.101634","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"5089_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/2589977515666221101153730","volume":"15","author":"N Saini","year":"2023","unstructured":"Saini N, Chopra B, Dhingra AK (2023) Synergistic effect of piperine and its derivatives: a comprehensive review. Current Drug Research Reviews Formerly: Current Drug Abuse Reviews 15(2):105\u2013121. https:\/\/doi.org\/10.2174\/2589977515666221101153730","journal-title":"Current Drug Research Reviews Formerly: Current Drug Abuse Reviews"},{"key":"5089_CR42","doi-asserted-by":"publisher","unstructured":"Sembiring EN, Elya B, Sauriasari R (2018) Phytochemical screening, total flavonoid and total phenolic content and antioxidant activity of different parts of Caesalpinia bonduc (L.) Roxb. Pharmacogn J 10(1). https:\/\/doi.org\/10.5530\/pj.2018.1.22","DOI":"10.5530\/pj.2018.1.22"},{"issue":"3\u20134","key":"5089_CR43","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/21553769.2013.879925","volume":"7","author":"M Stojan\u010devi\u0107","year":"2013","unstructured":"Stojan\u010devi\u0107 M, Pavlovi\u0107 N, Golo\u010dorbin-Kon S, Mikov M (2013) Application of bile acids in drug formulation and delivery. Front Life Sci 7(3\u20134):112\u2013122. https:\/\/doi.org\/10.1080\/21553769.2013.879925","journal-title":"Front Life Sci"},{"issue":"20","key":"5089_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/app9204270","volume":"9","author":"Z Stojanovi\u0107-Radi\u0107","year":"2019","unstructured":"Stojanovi\u0107-Radi\u0107 Z, Pej\u010di\u0107 M, Dimitrijevi\u0107 M, Aleksi\u0107 A, V Anil Kumar N, Salehi B, Sharifi-Rad J (2019) Piperine-a major principle of black pepper: a review of its bioactivity and studies. Appl Sci 9(20):4270. https:\/\/doi.org\/10.3390\/app9204270","journal-title":"Appl Sci"},{"key":"5089_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1127704","volume":"14","author":"M Strzelec","year":"2023","unstructured":"Strzelec M, Detka J, Mieszczak P, Soboci\u0144ska MK, Majka M (2023) Immunomodulation\u2014a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system. Front Immunol 14:1127704. https:\/\/doi.org\/10.3389\/fimmu.2023.1127704","journal-title":"Front Immunol"},{"key":"5089_CR46","doi-asserted-by":"publisher","unstructured":"Tabassum N, Sultana N, Ali A, Emad NA, Zaidi SAA, Jahan S, ..., Aqil M (2025) Thermosensitive transniosomal in situ gel of hesperetin for intranasal administration: novel approach for Parkinson\u2019s therapy. J Drug Target 1\u201318. https:\/\/doi.org\/10.1080\/1061186X.2025.2576112","DOI":"10.1080\/1061186X.2025.2576112"},{"issue":"2","key":"5089_CR47","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3897\/pharmacia.69.e80072","volume":"69","author":"SKK Taraka","year":"2022","unstructured":"Taraka SKK, Pasala PK, Sahoo RK, Laddha UD, Khairnar SJ, Bendale AR, Rudrapal M (2022) Atorvastatin ascorbic acid co-crystal strategy to improve the safety and efficacy of atorvastatin. Pharmacia 69(2):295\u2013302. https:\/\/doi.org\/10.3897\/pharmacia.69.e80072","journal-title":"Pharmacia"},{"key":"5089_CR48","doi-asserted-by":"publisher","unstructured":"Usmani Z, Jahan S, Usmani Z, Ahad A, Akhtar M, Aqil M, Mujeeb M (2025) Bipartite 5-fluorouracil and lepidine-based nanoemulsion gel: in vitro and dermatokinetic evaluation. J Drug Target (just-accepted) 1\u201317. https:\/\/doi.org\/10.1080\/1061186X.2025.2533333","DOI":"10.1080\/1061186X.2025.2533333"},{"issue":"7","key":"5089_CR49","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1080\/02678292.2020.1836276","volume":"48","author":"T Waghule","year":"2021","unstructured":"Waghule T, Patil S, Rapalli VK, Girdhar V, Gorantla S, Kumar Dubey S, Singhvi G (2021) Improved skin-permeated diclofenac-loaded lyotropic liquid crystal nanoparticles: QbD-driven industrial feasible process and assessment of skin deposition. Liq Cryst 48(7):991\u20131009. https:\/\/doi.org\/10.1080\/02678292.2020.1836276","journal-title":"Liq Cryst"},{"key":"5089_CR50","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ejpb.2022.10.015","volume":"180","author":"A Waheed","year":"2022","unstructured":"Waheed A, Zameer S, Sultana N, Ali A, Aqil M, Sultana Y, Iqbal Z (2022) Engineering of QbD driven and ultrasonically shaped lyotropic liquid crystalline nanoparticles for apigenin in the management of skin cancer. Eur J Pharm Biopharm 180:269\u2013280. https:\/\/doi.org\/10.1016\/j.ejpb.2022.10.015","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"5089_CR51","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12951-024-02446-z","volume":"22","author":"H Wang","year":"2024","unstructured":"Wang H, Tang C, Xiang Y, Zou C, Hu J, Yang G, Zhou W (2024) Tea polyphenol-derived nanomedicine for targeted photothermal thrombolysis and inflammation suppression. J Nanobiotechnology 22(1):146. https:\/\/doi.org\/10.1186\/s12951-024-02446-z","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"5089_CR52","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1080\/10717544.2019.1689313","volume":"27","author":"L Wu","year":"2020","unstructured":"Wu L, Zhao L, Su X, Zhang P, Ling G (2020) Repaglinide-loaded nanostructured lipid carriers with different particle sizes for improving oral absorption: preparation, characterization, pharmacokinetics, and in situ intestinal perfusion. Drug Deliv 27(1):400\u2013409. https:\/\/doi.org\/10.1080\/10717544.2019.1689313","journal-title":"Drug Deliv"},{"issue":"6","key":"5089_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/polym15061464","volume":"15","author":"RA Youness","year":"2023","unstructured":"Youness RA, Al-Mahallawi AM, Mahmoud FH, Atta H, Braoudaki M, Fahmy SA (2023) Oral delivery of psoralidin by mucoadhesive surface-modified bilosomes showed boosted apoptotic and necrotic effects against breast and lung cancer cells. Polymers 15(6):1464. https:\/\/doi.org\/10.3390\/polym15061464","journal-title":"Polymers"},{"key":"5089_CR54","doi-asserted-by":"publisher","first-page":"643119","DOI":"10.3389\/fphar.2021.643119","volume":"12","author":"N Yuandani","year":"2021","unstructured":"Yuandani N, Jantan I, Rohani AS, Sumantri IB (2021) Immunomodulatory effects and mechanisms of curcuma species and their bioactive compounds: a review. Front Pharmacol 12:643119. https:\/\/doi.org\/10.3389\/fphar.2021.643119","journal-title":"Front Pharmacol"},{"key":"5089_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.902551","volume":"13","author":"\u00c7 Y\u00fccel","year":"2022","unstructured":"Y\u00fccel \u00c7, Karatoprak G\u015e, A\u00e7\u0131kara \u00d6B, Akkol EK, Barak TH, Sobarzo-S\u00e1nchez E, Shirooie S (2022) Immunomodulatory and anti-inflammatory therapeutic potential of gingerolsandtheirnanoformulations. Frontiersinpharmacology 13:902551. https:\/\/doi.org\/10.3389\/fphar.2022.902551","journal-title":"Frontiersinpharmacology"},{"issue":"3","key":"5089_CR56","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jsps.2021.02.003","volume":"29","author":"A Zafar","year":"2021","unstructured":"Zafar A, Alruwaili NK, Imam SS, Alotaibi NH, Alharbi KS, Afzal M, Hadal Alotaibi N, Ali R, Alshehri S, Alzarea SI, Elmowafy M, Alhakamy NA, Ibrahim MF (2021) Bioactive apigenin loaded oral nano bilosomes: formulation optimization to preclinical assessment. Saudi Pharm J 29(3):269\u2013279. https:\/\/doi.org\/10.1016\/j.jsps.2021.02.003","journal-title":"Saudi Pharm J"},{"issue":"1","key":"5089_CR57","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1080\/10717544.2021.2008055","volume":"28","author":"A Zafar","year":"2021","unstructured":"Zafar A, Alruwaili NK, Imam SS, Alsaidan OA, Yasir M, Ghoneim MM, Alshehri S, Anwer MK, Almurshedi AS, Alanazi AS (2021) Development and evaluation of luteolin loaded pegylated bilosome: optimization, in vitro characterization, and cytotoxicity study. Drug Deliv 28(1):2562\u20132573. https:\/\/doi.org\/10.1080\/10717544.2021.2008055","journal-title":"Drug Deliv"},{"issue":"7","key":"5089_CR58","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-021-02098-4","volume":"22","author":"A Zafar","year":"2021","unstructured":"Zafar A, Alruwaili NK, Imam SS, Alsaidan OA, Alharbi KS, Yasir M, Al-Oanzi ZH (2021) Formulation of chitosan-coated piperine NLCs: optimization, in vitro characterization, and in vivo preclinical assessment. AAPS PharmSciTech 22(7):231. https:\/\/doi.org\/10.1208\/s12249-021-02098-4","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"5089_CR59","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1080\/10717544.2021.1934190","volume":"28","author":"MY Zakaria","year":"2021","unstructured":"Zakaria MY, Fayad E, Althobaiti F, Zaki I, Abu Almaaty AH (2021) Statistical optimization of bile salt deployed nanovesicles as a potential platform for oral delivery of piperine: accentuated antiviral and anti-inflammatory activity in MERS-CoV challenged mice. Drug Deliv 28(1):1150\u20131165. https:\/\/doi.org\/10.1080\/10717544.2021.1934190","journal-title":"Drug Deliv"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05089-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05089-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05089-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:20:11Z","timestamp":1781511611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05089-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["5089"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05089-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}